Compare GSK plc (GSK) vs KraneShares CSI China Internet ETF (KWEB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
GSK plc vs KraneShares CSI China Internet ETF — how do they compare? GSK plc trades at $46.82 (market cap $91.88B), while KraneShares CSI China Internet ETF trades at $24.5 (market cap $4.37B). The key difference: GSK plc is far larger — about 21× KraneShares CSI China Internet ETF's market cap, and GSK plc pays a 3.9% dividend while KraneShares CSI China Internet ETF pays none. Which is the better fit depends on your goals — on Pluang, investors hold GSK plc for 93 Days and KraneShares CSI China Internet ETF for 57 Days on average.
| GSK | KWEB | |
|---|---|---|
Market Cap | $91.88B | $4.37B |
Volume | 7,730,529 | 13,393,361 |
Sector | Health | Sector/Thematic |
52-Week High | $61.18 | $41.35 |
52-Week Low | $43.24 | $23.63 |
Typical Hold Time | 93 Days | 57 Days |
Enterprise Value | $111.88B | — |
Dividend Yield | 3.9% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
GSK trades at $47.02, up 0.9% with a P/E of 14.89, trading below industry averages. The stock shows strong profitability with 72.73% gross margins and 29.73% ROE, though technical indicators signal bearish momentum. Recent earnings beats and strategic oncology investments highlight growth potential amid patent cliff concerns.
GSK's valuation appears attractive with earnings momentum, but faces headwinds from technical weakness and HIV patent expirations. The bullish analyst sentiment (31% buy ratings) and pipeline innovation provide upside, while cost-saving initiatives and dividend yield offer stability. Key risks include competitive pressures and execution on £40B sales targets.
KWEB trades at $24.33, down 0.86% on the day, with a bearish technical outlook driven by moving averages and a neutral oscillator stance. The ETF faces headwinds from China's economic challenges, including industrial overcapacity and weak domestic demand, as highlighted in recent news. Institutional activity is mixed, with some firms reducing stakes while others increase holdings, reflecting uncertainty in the China internet sector.
The outlook for KWEB remains cautious due to geopolitical tensions and economic pressures in China. Investment opportunities hinge on potential trade improvements from U.S.-China dialogues, but risks include persistent regulatory concerns and global protectionism. Investors should weigh the ETF's exposure to China's internet stocks against these macroeconomic and sentiment-driven volatilities.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About GSK plc
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, cancer, and antiviral, as well as vaccines. GSK uses joint ventures to gain additional scale in certain markets like HIV.
Read more on GSK →About KraneShares CSI China Internet ETF
KWEB tracks the CSI Overseas China Internet Index, providing exposure to Chinese software and services companies listed in the US and Hong Kong, including giants like Tencent, Alibaba, and Meituan.
Read more on KWEB →
